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Abstract
Background: Cemented total hip arthroplasty (THA) is a safe and common procedure. In rare cases life threatening
bone cement implantation syndrome (BCIS) may occur, which is commonly caused by pulmonary embolism (PE).
Case presentation: We describe the rare case of a 70-year old patient who underwent an elective total hip
replacement. Before surgery he was diagnosed with underlying systemic indolent mastocytosis, a rare pathological
disorder that may result in anaphylaxis after massive systemic mast cell activation. Triggers may be IgE-mediated,
direct mast cell activation, or unclear. Some patients may be at risk for severe non IgE-mediated reactions, such as
those experienced with nonsteroidal anti-inflammatory drugs, or with perioperative muscle relaxants. During
cementing of the acetabular component, our patient developed acute hypotension (blood pressure dropped from
90/50 to 60/40 mmHg, and saturation dropped from 95 to 80 %). The differential diagnosis of acute PE was
excluded (no signs of breathing abnormalities during physical examination, normal arterial blood sample, and no
electrocardiography or cardiac ultrasound abnormalities). The patient was diagnosed with acute anaphylactic shock,
which was successfully managed by 100 % oxygen administration, rapid fluid induction, and vasoconstrictive drug
therapy. He recovered hemodynamically within 15 min, did not lose consciousness, and did not develop
angioedema or an urticarial rash. Forty-five minutes after onset of the symptoms, the surgical procedure was
completed after inserting a press fitted uncemented femoral stem component. The patient was transported to the
Intensive Care Unit (ICU) for optimal monitoring. Our patient had an uneventful recovery. Within six hours after
surgery he started to ambulate following our standard fast-track rehabilitation regime. Post-operative day one he
was discharged to the specialized Orthopedic Department, and after five hospital days discharged to his home.
Twelve months after THA surgery our patient was satisfied with an optimal functional status of his hip joint
replacement.
Conclusion: The differential diagnosis of anaphylactic shock must be taken into consideration in patients with
acute hypotension during cementing of total hip arthroplasty components. Patients with underlying mastocytosis
are at particular risk of this potential life-threatening intra-operative complication. This rare entity should be taken
into consideration during the pre-operative risk stratification and shared decision-making process for elective
cemented joint replacement.
Keywords: Mastocytosis, Bone cement, Implantation syndrome, Anaphylaxis, Hip surgery, Case report
* Correspondence: t.m.vanraaij@mzh.nl
2Department of Orthopaedic Surgery, Martini Hospital Groningen, van
Swietenplein 1, 9728 NT Groningen, The Netherlands
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
ten Hagen et al. Patient Safety in Surgery  (2016) 10:25 
DOI 10.1186/s13037-016-0113-x
Background
BCIS is characterized by a number of clinical features
that may include hypoxia, hypotension, cardiac arrhyth-
mias, increased pulmonary vascular resistance, and car-
diac arrest. BCIS is most commonly associated with hip
arthroplasty, and usually occurs at one of the five stages
in the surgical procedure; femoral reaming, acetabular
or femoral cement implantation, insertion of the pros-
thesis or joint reduction [1]. High incidence with severe
reactions has been reported in cemented hemi-
arthroplasty after a proximal femur fracture. In elective
THA surgery the incidence has been much lower, but
still the rate of intraoperative mortality is about 0.1 %
[2]. Diverse mechanisms have been postulated as causing
BCIS [1]. An anaphylactoid mechanism as a major factor
contributing to the development of BCIS remains dis-
puted. Earlier, Tryba et al. showed increased levels of
plasma histamine in elderly patients with hip fractures
after the implantation of acrylic bone cement into the
femur [3]. Mitsuhata et al. concluded that methylmetha-
crylate bone cement does not release histamine during
total hip replacement surgery [4]. A randomized trial in
50 patients receiving cemented hip arthroplasty could
not demonstrate a prophylactic potential for histamine-
receptor blocking agents in BCIS [5]. Since then, many
studies have suggested that pulmonary embolization is
the main cause in BCIS [1]. Mastocytosis is a rare patho-
logical disorder that may result in anaphylaxis after
massive systemic mast cell activation. Triggers may be
IgE-mediated, direct mast cell activation, or unclear.
IgE-mediated anaphylaxis to drugs and foods are not
well studied [6]. We describe a patient diagnosed with
systemic indolent mastocytosis who most likely devel-
oped an anaphylactoid BCIS response after acetabular
component cementation in elective total hip surgery.
Case presentation
A-70-year-old man with symptomatic osteoarthritis of
the right hip, weighing 79 kg, tall 177 cm was presenting
for a primary THA. He was recently diagnosed with sys-
temic indolent mastocytosis with multiple sclerotic and
osteolytic laesions. History showed no allergic reactions
in the past. In 1998 cannulated hip screws were used to
treat a left proximal transcervical femur fracture suc-
cessfully. Multiple insufficiency vertebra fractures were
treated non-operative in 2015. A multimodal oral anal-
gesic regime consisting of paracetamol 1 g, naproxen
500 mg and gabapentin 600 mg was administered 1–2 h
pre-operatively. On the pre-anesthetic care unit the
blood pressure was 150/95 mmHg with a saturation of
95 % and 11,85 mg Dexamethasone and Cefazoline
2000 mg soluted in 20 ml Sodiumchloride (NaCl) 0.9 %
was administered intravenously. In the operating room
spinal anesthesia with 7.5 mg bupivacaine 0,5 % plain via
the L2/3 vertebral interspace with a standardized intra-
operative regime for fluid administration, consisting of
0,9 % saline (500 ml) was given. After spinal anesthesia
the patient received sedation with propofol TCI 0,8 ug/
ml (0,1–2.0 ug/ml). To reduce blood loss, tranexamic
acid 1000 mg was given at the beginning of surgery. To
reduce nausea and vomiting ondansteron 4 mg IV is
added in this multimodal regimen. To reduce chronic
pain, ketamine 15 mg IV is titrated after starting the sed-
ation. The blood pressure was 120/70 mmHg after spinal
anesthesia and starting the sedation. Three liter of Oxy-
gen was added during sedation. Thirty minutes after in-
duction the orthopedic surgeon inserted a cemented
acetabular component. Blood pressure dropped from 90/
50 to 60/40 mmHg. Saturation dropped from 95 to
80 %. Oxygen 100 % with a Ventimask was administered
and rapid infusion of NaCl 0.9 % 1000 ml as well as
Phenylephrine 4 × 100 ug, phenypephrine 2 × 200 ug
and 10 mg ephedrine was given intravenously. Phenyl-
ephrine infusion was started and replaced by Noradren-
aline 5 mg/50 ml NaCl 0.9 % 2.0–9.0 ml/h. The breath
sounds remained normal, and no angioedema, urticaria
or rash occurred. All the time, the patient was conscious
and able to respond questions. With rapid infusion and
finally Noradrenaline he recovered hemodynamically
within 15 min, blood pressure 100/50 mmHg with 95 %
saturation. Forty-five minutes after onset of the symp-
toms, the surgical procedure was completed after insert-
ing a press fitted uncemented femoral stem component.
The patient was transported to the Intensive Care Unit
(ICU) for optimal postoperative treatment and monitor-
ing. Biochemistry showed stable hemoglobin levels
(8.3 mmol/l on ICU arrival and 8.4 mmol/l after 4 h), el-
evated white blood cell count (19.3 × 109/l), normal
levels of electrolytes, liver enzymes, creatine kinase and
troponin, and an arterial blood sample of pH 7.36 pCO2
6.1 kPa; pO2 14.4 kPa; HCO3 26 mmol/l; Base excess
0.4 mmol/l; Fys. O2 sat 98.7 %; FiO2 30 %; lactic acid
1.0 mmol/l. Electrocardiography (on ICU arrival and
after 24 h) remained normal, and echocardiography
showed no left or right ventricular disfunctioning or ele-
vation of the right atrial pressure. Within six hours after
surgery the patient started to ambulate following our
standard fast-track rehabilitation regime. Post-operative
day one he was discharged according strict functional
criteria to the specialized Orthopedic Department. After
5 hospital days the patient was discharged to his home.
Discussion
BCIS has been observed in prosthetic hip surgery for
many years, and is still not fully understood. A severity
classification has been proposed; grade 1: moderate hyp-
oxia (SpO2,94 %) or hypotension [fall in systolic blood
pressure (SBP) .20 %], grade 2: severe hypoxia (SpO2
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,88 %) or hypotension (fall in SBP .40 %) or unexpected
loss of consciousness, and grade 3: cardiovascular col-
lapse requiring cardiopulmonary resuscitation [1]. In our
case a grade 2 BCIS occurred after cementing the ace-
tabular component; systemic blood pressure drop more
than 30 % and severe hypoxia (saturation 80 %). The pa-
tient recovered in 15 min after rapid fluid induction,
100 % oxygen administration, and vasoconstrictive drug
therapy. He did not lose consciousness, did not develop
angioedema or an urticarial rash, and remained
hemodynamic stable with blood loss not more than ex-
pected after elective hip surgery. All our eligible patients
receive cemented acetabular components during total
hip surgery. Nationwide registry shows better perform-
ance of cemented cups over uncemented cups [7]. Also
less damage to the acetabular host bone with a cemented
component during future revision surgery is to be ex-
pected [8]. Acetabular pressure rises after cup place-
ment, especially during cementation, and an average of
375 mmHg has been reported [9]. As a consequence ex-
trusion of bone marrow content with diffuse microem-
bolism of the lungs may occur. In our case pulmonary
fat embolism was excluded; there were no signs of
breathing abnormalities during physical examination,
only a short period of hypoxia occurred, and no electro-
cardiography or cardiac ultrasound abnormalities were
encountered. Normovolemic hypotension without angio-
edema or rash may also be caused by an anaphylactoid
mechanism observed in mastocytosis [6]. Recently our
patient was diagnosed with systemic indolent mastocyto-
sis through an iliac crest biopsy. Anaphylaxis in masto-
cytosis can be either IgE-mediated or non IgE-mediated,
such as those experienced with nonsteroidal anti-
inflammatory drugs or muscle relaxants. In our hospital
all primary THA patients undergo a standardized
anesthesia, analgesia and perioperative program to en-
hance recovery. Low dose bupivacaine and a multimodal
opioid-sparing regimen facilitate early mobilization and
allow rehabilitation to be initiated a few hours postoper-
atively. Our patient received intravenous nonsteroidal
anti-inflammatory drugs at least one hour preopera-
tively, and no muscle relaxants were given. The acute re-
sponse after cement application suggests a reaction on
polymethylmethacrylate (PMMA) bone cement. Earlier,
PMMA mediated histamine release with increased
plasma histamine concentrations after bone cement im-
plantation in the femoral shaft has been described [4].
More recent hypersensitivity to PMAA following joint
replacement has also been reported [10, 11]. Krüger
et al. described a patient with mastocytosis who under-
went kyphoplasty for multiple osteoporotic vertebral
fractures using radiopaque calcium phosphate bone ce-
ment under antihistamine and prednisolone coverage
[12]. Arterial hypotension was encountered that
transiently required vasopressor support. The critical
threshold of intramedullary pressure that causes fat em-
bolism is unclear, but pressure peaks as great as
300 mmHg were found to produce significant bone mar-
row release [13]. Intravertebral pressure during kypho-
plasty, however, is substantially lower, and remains well
below 300 mmHg [14]. A pressure-induced mast cell de-
granulation mechanism seems more suitable. Although
rare an allergic reaction to calcium phosphate cement
has been noted in skull reconstruction [15]. Even severe
hypoxia with ventricular failure as a sign of possible ag-
gregate anaphylaxis has been seen after formation of
intravenous calcium phosphate precipitant [16]. There-
fore, it seems more likely that Krügers’ observation and
our case highlight the capacity of bone cement to trigger
a disproportionate display of mast cell activity in masto-
cytosis patients with a BCIS response as a result. The
use of corticosteroids has been advised to prevent ana-
phylaxis in patient with mastocytosis. In both patients
corticosteroids were administered before intervention,
which did not prevent BCIS unfortunately.
Conclusion
Our case suggests a disproportionate response to
PMMA bone cement, which lead to anaphylactic shock.
Patients with underlying mastocytosis are at particular
risk of this potential life-threatening intra-operative
complication. This rare entity should be taken into con-
sideration during the preoperative risk stratification and





No funding was obtained for the design of the study and collection, analysis,
and interpretation of data and in writing the manuscript.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or
analysed during the current study.
Authors’ contributions
AH, PD and TR made substantial contributions to conception and design,
acquisition of data, and analysis and interpretation of data; All authors have
been involved in drafting the manuscript and revising it critically for
important intellectual content; All authors have given final approval of the
version to be published. Each author has participated sufficiently in the work
to take public responsibility for appropriate portions of the content; and all
authors agreed to be accountable for all aspects of the work in ensuring that
questions related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent for publication of their clinical details was
obtained from the patient.
ten Hagen et al. Patient Safety in Surgery  (2016) 10:25 Page 3 of 4
Ethics approval and consent to participate
N/A.
Author details
1Department of Anesthesiology, Martini Hospital Groningen, Van
Swietenplein 1, 9728 NT Groningen, The Netherlands. 2Department of
Orthopaedic Surgery, Martini Hospital Groningen, van Swietenplein 1, 9728
NT Groningen, The Netherlands.
Received: 5 October 2016 Accepted: 27 October 2016
References
1. Donaldson AJ, Thomson HE, Harper NJ, Kenny NW. Bone cement
implantation syndrome. Br J Anaesth. 2009;102(1):12–22. doi:10.1093/bja/
aen328. Review.
2. Griffiths R, Parker M. Bone cement implantation syndrome and proximal
femoral fracture. Br J Anaesth. 2015;114(1):6–7. doi:10.1093/bja/aeu264. Epub
2014 Aug 21.
3. Tryba M, Linde I, Voshage G, Zenz M. Histamine release and cardiovascular
reactions to implantation of bone cement during total hip replacement.
Anaesthesist. 1991;40(1):25–32.
4. Mitsuhata H, Saitoh J, Saitoh K, Fukuda H, Hirabayasi Y, Shimizu R, Hasegawa
J, Matsumoto S, Enzan K. Methylmethacrylate bone cement does not
release histamine in patients undergoing prosthetic replacement of the
femoral head. Br J Anaesth. 1994;73(6):779–81.
5. Lamadé WR, Friedl W, Schmid B, Meeder PJ. Bone cement implantation
syndrome. A prospective randomised trial for use of antihistamine blockade.
Arch Orthop Trauma Surg. 1995;114(6):335–9.
6. Akin C. Mast cell activation syndromes presenting as anaphylaxis. Immunol
Allergy Clin North Am. 2015;35(2):277–85. doi:10.1016/j.iac.2015.01.010.
7. Hailer NP, Garellick G, Kärrholm J. Uncemented and cemented primary total
hip arthroplasty in the Swedish Hip Arthroplasty Register. Acta Orthop.
2010;81(1):34–41. doi:10.3109/17453671003685400.
8. Lazarinis S, Milbrink J, Mattsson P, Mallmin H, Hailer NP. Bone loss around a
stable, partly threaded hydroxyapatite-coated cup: a prospective cohort
study using RSA and DXA. Hip Int. 2014;24(2):155–66. doi:10.5301/hipint.
5000104. Epub 2014 Feb 3.
9. New AM, Northmore-Ball MD, Tanner KE, Cheah SK. In vivo measurement of
acetabular cement pressurization using a simple new design of cement
pressurizer. J Arthroplasty. 1999;14(7):854–9.
10. Erpenbach J, Hofmeister E. Hypersensitivity to polymethylmethacrylate
following shoulder hemiarthroplasty. Orthopedics. 2008;31(7):708.
11. Kaplan K, Della Valle CJ, Haines K, Zuckerman JD. Preoperative identification
of a bone-cement allergy in a patient undergoing total knee arthroplasty. J
Arthroplasty. 2002;17(6):788–91.
12. Krüger A, Hamann C, Brendel C, Ramaswamy A, Schnabel M, Neubauer A,
Hofbauer LC. Multimodal therapy for vertebral involvement of systemic
mastocytosis. Spine (Phila Pa 1976). 2009;34(17):E626–8. doi:10.1097/BRS.
0b013e3181a6bc4f.
13. Hofmann S, Hopf R, Huemer G, Kratochwill C, Koller-Strametz J, Schlag G,
Salzer M. Modified surgical technique for reduction of bone marrow spilling
in cement-free hip endoprosthesis. Orthopade. 1995;24(2):130–7.
14. Wang Y, Huang F, Chen L, Ke ZY, Deng ZL. Clinical measurement of
intravertebral pressure during vertebroplasty and kyphoplasty. Pain
Physician. 2013;16(4):E411–8.
15. Mizowaki T, Miyake S, Yoshimoto Y, Matsuura Y, Akiyama S. Allergy of
calcium phosphate cement material following skull reconstruction: a case
report. No Shinkei Geka. 2013;41(4):323–7.
16. Felton TW, McCormick BA, Finfer SR, Fisher MM. Life-threatening pulmonary
hypertension and right ventricular failure complicating calcium and phosphate
replacement in the intensive care unit. Anaesthesia. 2006;61(1):49–53.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
ten Hagen et al. Patient Safety in Surgery  (2016) 10:25 Page 4 of 4
